Martin J Edelman, MD
Professor of Medicine and Director of Medical Thoracic Oncology, University of Maryland Greenebaum Cancer Center
Prof Edelman is the author of over 200 articles, abstracts, and book chapters. He is a world-renowned expert in thoracic cancer, and developed one of the most commonly used regimens for treating advanced lung cancer and has focused on the development of biomarkers to personalize lung cancer therapy.
He serves on the Lung Cancer committee of the Cancer and Leukemia Group B (CALGB) / Alliance National Cancer Institute-sponsored Clinical Research Group; as the Medical Oncology co-chair for the Lung Cancer Committee of the Radiation Therapy Oncology Group (RTOG); as a leader of the International Association for the Study of Lung Cancer (IASLC); and as a Faculty Member of the European Society of Medical Oncology where he is assisting in the drafting of international guidelines for the clinical treatment of lung cancer.